News

Venus Concept Set to Unveil Exciting Financial Results Soon

Venus Concept Set to Unveil Exciting Financial Results Soon

Venus Concept Prepares to Present Financial Results

Venus Concept Inc. (NASDAQ: VERO), a leader in medical aesthetic technology, is gearing up to share its second-quarter financial results for fiscal year 2025. The anticipated announcement will occur on a Thursday, a day in August that marks an important moment for both investors and stakeholders.

Insights into the Results

The financial results are set to be disclosed after the stock market closes, heralding a period of excitement among investors eager to assess the company's performance and future aspirations. The company's management team will hold a conference call at 5:00 PM Eastern Time to delve into the results and engage with shareholders through a question and answer session. For those who wish to join, they can easily call in using the designated phone numbers provided for both domestic and international callers.

Engagement and Accessibility of Information

For individuals who may not be available at the scheduled time of the call, rest assured that a replay will be accessible for two weeks after the event. Participants can easily reach this replay by calling the specified phone numbers, ensuring that all interested parties can remain informed about the latest updates from Venus Concept.

Exploring the Company’s Innovations

As a recognized innovator in the medical aesthetic domain, Venus Concept showcases an extensive portfolio of products designed for minimally invasive and non-invasive procedures. With a strong commitment to progress, the company operates in over 60 countries while maintaining direct market access in nine locations.

The Technology Behind Venus Concept

Venus Concept's array of aesthetic devices includes renowned names such as Venus Versa, Venus Legacy, and Venus Viva, catering to diverse treatment needs. Their product offerings are complemented by advanced hair restoration technologies like NeoGraft and the ARTAS iX Robotic Hair Restoration system, underscoring their dedication to improving aesthetic outcomes for patients worldwide.

Strategic Partnerships and Investment

Backed by a coalition of healthcare industry equity investors, Venus Concept continues to navigate the evolving landscape of medical aesthetics. Their relationships with prominent investment institutions position them for sustained growth and innovation, driving their mission to provide accessible technology that transforms aesthetic practices.

Contact Information for Investor Relations

Investors and interested stakeholders are encouraged to reach the company through their Investor Relations contact, Mike Piccinino, CFA. For inquiries, one can send an email to VenusConceptIR@ICRHealthcare.com to receive timely information and support.

Frequently Asked Questions

When will Venus Concept release its financial results?

The company will announce its financial results after the market closes on a Thursday in August 2025.

How can I participate in the conference call?

Participants can dial the provided numbers for domestic and international callers to join the call at 5:00 PM Eastern Time.

Is there a way to access a recording of the conference call?

Yes, the call will be available as a replay for two weeks following the event.

What technology does Venus Concept offer?

Venus Concept offers a wide range of aesthetic devices and hair restoration technologies, focusing on minimally invasive procedures.

Who should I contact for investor inquiries?

For any investor-related questions, contact Mike Piccinino at VenusConceptIR@ICRHealthcare.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Cutting-Edge Innovations from GrowGeneration at Cultivate'25

Updated Category News Views 135

Exciting Innovations at Cultivate'25 GrowGeneration Corp. (NASDAQ: GRWG), a leading name in hydroponic retail, is gearing up to demonstrate its cutting-edge products at Cultivate'25. This premier horticulture trade show is a golden opportunity for lawn and garden professionals, greenhouses, and nurseries to witness firsthand the innovations that are transforming...

Continue Reading
Cellectar Biosciences Showcases Breakthrough Cancer Treatment Data

Updated Category News Views 153

Innovative Cancer Treatment Presentation by Cellectar Biosciences Cellectar Biosciences, Inc. (NASDAQ: CLRB), a pioneering biopharmaceutical entity, is making waves in the field of oncology with its recent presentation at a renowned cancer research conference. The company announced its positive preclinical data for CLR 121225, showcasing its potential as a groundbreaking...

Continue Reading
Fidelity National Financial's Strategic $500 Million Notes Offering

Updated Category News Views 58

Fidelity National Financial Secures $500 Million in Senior Notes Fidelity National Financial (NYSE: FNF), a prominent player in title insurance and transaction services, has made waves with the recent announcement of a successful public offering of $500 million in senior notes via its subsidiary, F&G Annuities & Life, Inc. This strategic move is poised to bolster the...

Continue Reading
Centering Healthcare Institute Gains Investment to Enhance Care Model

Updated Category News Views 65

Centering Healthcare Institute Secures $7.6 Million Investment Centering Healthcare Institute (CHI) has announced an exciting new chapter in its mission to enhance healthcare delivery with a recent investment of $7.6 million from The Studio @ Blue Meridian. This significant funding will allow CHI to implement a strategic three-year plan focused on scaling its services and...

Continue Reading
Leadership Changes at Ring Energy: New CFO Transition Strategy

Updated Category News Views 275

Ring Energy's Recent Leadership Transition Ring Energy, Inc. has recently made headlines with the announcement of a significant shift in its leadership. The company has confirmed that Travis T. Thomas, the former Chief Financial Officer (CFO), has resigned from his position to pursue new opportunities. This transition marks an important moment for the organization and...

Continue Reading